Penumbra, Inc. rose 2.19% in intraday trading, with the company presenting at Canaccord Genuity's 45th Growth Conference. The presentation, led by senior medical device analyst Bill Plovanic, is likely to have generated positive investor sentiment, contributing to the stock's upward movement.
Comments
No comments yet